Tag: Lifileucel
Iovance Biotherapeutics Announces 33-Month Follow Up Data for Lifileucel in Advanced...
Median Duration of Response (DOR) Not Reached at 33.1 Months of Median Study Follow Up in Cohort 2 in C-144-01 Study ...
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma...
Median Duration of Response Not Reached at 28.1 Months of Median Study Follow Up in Cohort 2 of C-144-01 Study 36.4% Overall Response...